Bashir Masrat, Dar Aijaz A, Yousuf Imtiyaz
Department of Chemistry, Aligarh Muslim University, Aligarh202002, Uttar Pradesh, India.
Department of Chemistry, University of Kashmir, Hazratbal, Srinagar190006, Jammu & Kashmir, India.
ACS Omega. 2023 Jan 11;8(3):3026-3042. doi: 10.1021/acsomega.2c05927. eCollection 2023 Jan 24.
This work describes the syntheses, structural characterization, and biological profile of Mn(II)- and Zn(II)-based complexes and derived from the aroyl-hydrazone Schiff base ligand (). The synthesized compounds were thoroughly characterized by elemental analysis, Fourier transform infrared spectroscopy (FTIR), UV-vis, electron paramagnetic resonance (EPR), nuclear magnetic resonance (NMR), and single-crystal X-ray diffraction (s-XRD). Density functional theory (DFT) studies of complexes and were performed to ascertain the structural and electronic properties. Hirshfeld surface analysis was used to investigate different intermolecular interactions that define the stability of crystal lattice structures. To ascertain the therapeutic potential of complexes and , interaction studies were carried out with ct-DNA and bovine serum albumin (BSA) using analytical and multispectroscopic techniques, and the results showed more avid binding of complex than complex and . The antioxidant potential of complexes and was examined against the 2,2-diphenyl picrylhydrazyl (DPPH) free radical, which revealed better antioxidant ability of the Mn(II) complex. Moreover, the antibacterial activity of synthesized complexes and was tested against Gram-positive and Gram-negative bacteria in which complex demonstrated more effective bactericidal activity than and complex toward Gram-positive bacteria. Furthermore, the cytotoxicity assessment of and complexes and was carried out against MDA-MB-231 (triple negative breast cancer) and A549 (lung) cancer cell lines. The cytotoxic results revealed that the polymeric Zn(II) complex exhibited better and selective cytotoxicity against the A549 cancer cell line as was evidenced by its low IC value.
本工作描述了基于Mn(II)和Zn(II)的配合物的合成、结构表征及生物学特性,这些配合物衍生自芳酰腙席夫碱配体()。通过元素分析、傅里叶变换红外光谱(FTIR)、紫外可见光谱、电子顺磁共振(EPR)、核磁共振(NMR)和单晶X射线衍射(s-XRD)对合成的化合物进行了全面表征。对配合物和进行了密度泛函理论(DFT)研究,以确定其结构和电子性质。使用 Hirshfeld 表面分析来研究定义晶格结构稳定性的不同分子间相互作用。为了确定配合物和的治疗潜力,使用分析和多光谱技术对其与 ct-DNA 和牛血清白蛋白(BSA)进行了相互作用研究,结果表明配合物比配合物具有更强的结合能力。通过2,2-二苯基苦味酰基肼(DPPH)自由基检测了配合物和的抗氧化潜力,结果表明Mn(II)配合物具有更好的抗氧化能力。此外,测试了合成配合物和对革兰氏阳性菌和革兰氏阴性菌的抗菌活性,其中配合物对革兰氏阳性菌的杀菌活性比配合物和更强。此外,还对配合物和对MDA-MB-231(三阴性乳腺癌)和A549(肺癌)癌细胞系进行了细胞毒性评估。细胞毒性结果表明,聚合物Zn(II)配合物对A549癌细胞系表现出更好的选择性细胞毒性,其低IC值证明了这一点。